国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ehrlichia ruminantium Translation initiation factor IF-2 (infB), partial CSB-YP688982EAY
CSB-EP688982EAY
CSB-BP688982EAY
CSB-MP688982EAY
CSB-EP688982EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP688983EAY
CSB-EP688983EAY
CSB-BP688983EAY
CSB-MP688983EAY
CSB-EP688983EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP688984EAY
CSB-EP688984EAY
CSB-BP688984EAY
CSB-MP688984EAY
CSB-EP688984EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP688985EAY
CSB-EP688985EAY
CSB-BP688985EAY
CSB-MP688985EAY
CSB-EP688985EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium Proline--tRNA ligase (proS) CSB-YP688986EAY
CSB-EP688986EAY
CSB-BP688986EAY
CSB-MP688986EAY
CSB-EP688986EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP688987EAY
CSB-EP688987EAY
CSB-BP688987EAY
CSB-MP688987EAY
CSB-EP688987EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium Chromosomal replication initiator protein DnaA (dnaA) CSB-YP688988EAY
CSB-EP688988EAY
CSB-BP688988EAY
CSB-MP688988EAY
CSB-EP688988EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium Trigger factor (tig) CSB-YP688989EAY
CSB-EP688989EAY
CSB-BP688989EAY
CSB-MP688989EAY
CSB-EP688989EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium UPF0434 protein Erum1340/ERWE_CDS_01300 (Erum1340, ERWE_CDS_01300) CSB-YP688990EAY
CSB-EP688990EAY
CSB-BP688990EAY
CSB-MP688990EAY
CSB-EP688990EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium 50S ribosomal protein L25 (rplY) CSB-YP688991EAY
CSB-EP688991EAY
CSB-BP688991EAY
CSB-MP688991EAY
CSB-EP688991EAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia ruminantium Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP688992EAY1
CSB-EP688992EAY1
CSB-BP688992EAY1
CSB-MP688992EAY1
CSB-EP688992EAY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Lactonase drp35 (drp35) CSB-YP688993FLB
CSB-EP688993FLB
CSB-BP688993FLB
CSB-MP688993FLB
CSB-EP688993FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Imidazole glycerol phosphate synthase subunit HisH (hisH) CSB-YP688994FLB
CSB-EP688994FLB
CSB-BP688994FLB
CSB-MP688994FLB
CSB-EP688994FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Lipase 1 (lip1) CSB-YP688995FLB
CSB-BP688995FLB
CSB-MP688995FLB
CSB-EP688995FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Protein translocase subunit SecA 2 (secA2), partial CSB-YP688996FLB
CSB-EP688996FLB
CSB-BP688996FLB
CSB-MP688996FLB
CSB-EP688996FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Aspartate 1-decarboxylase (panD) CSB-YP688997FLB
CSB-EP688997FLB
CSB-BP688997FLB
CSB-MP688997FLB
CSB-EP688997FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 1-pyrroline-5-carboxylate dehydrogenase (rocA), partial CSB-YP688999FLB
CSB-EP688999FLB
CSB-BP688999FLB
CSB-MP688999FLB
CSB-EP688999FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus D-lactate dehydrogenase (ldhD) CSB-YP689000FLB
CSB-EP689000FLB
CSB-BP689000FLB
CSB-MP689000FLB
CSB-EP689000FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Uncharacterized lipoprotein SACOL2498 (SACOL2498) CSB-YP689001FLB
CSB-EP689001FLB
CSB-BP689001FLB
CSB-MP689001FLB
CSB-EP689001FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Biotin synthase (bioB) CSB-YP689002FLB
CSB-EP689002FLB
CSB-BP689002FLB
CSB-MP689002FLB
CSB-EP689002FLB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>